Keryx Investors Seek Class Cert. In Kidney Drug Stock Case
A Keryx Biopharmaceuticals Inc. investor on Tuesday urged a Massachusetts federal judge to certify a class of shareholders he claims lost money after the company allegedly concealed potential problems with manufacturing...To view the full article, register now.
Already a subscriber? Click here to view full article